Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rashmi Kadam

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Indian Journal of Medical Ethics|August 7, 2012
Proactive role for ethics committeesRashmi Kadam
Perspectives in Clinical Research|June 16, 2012
Ethics committees in India: Facing the challenges!Rashmi Kadam, Shashikant Karandikar
Autophagy|June 19, 2026
Optineurin, an autophagy adaptor, stabilizes Rictor to maintain Akt/mTOR signaling and antigen presentationRashmi Kadam, Deepak Shukla
Journal of Leukocyte Biology|June 13, 2024
Brain-immune interactions: implication for cognitive impairments in Alzheimer's disease and autoimmune disordersRashmi Kadam, Muskan Gupta, Orly Lazarov, et al.
Perspectives in Clinical Research|May 4, 2016
Opinions and perceptions regarding the impact of new regulatory guidelines: A survey in Indian Clinical Trial InvestigatorsRashmi Kadam, Sanghratna Borde, Sapna Madas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 4, 2026
Optineurin restrains IL-17-associated neuroinflammation in trigeminal ganglia to preserve sensory function after ocular HSV-1 infectionJoshua Ames, Rashmi Kadam, Tejabhiram Yadavalli, et al.
Clinical and Translational Medicine|June 10, 2025
MLKL‒OPTN axis regulates herpesvirus-induced neurological sequelaeIlina Bhattacharya, Rashmi Kadam, Tejabhiram Yadavalli, et al.
Cell Reports|April 17, 2026
Optineurin modulates mTORC2/AKT/STAT3 signaling to control MHC class II expression and adaptive immunity against HSV-1Rashmi Kadam, Chandrashekhar Patil, Leonid Feferman, et al.
Cell Reports|October 3, 2019
A Small-Molecule Pan-Id Antagonist Inhibits Pathologic Ocular NeovascularizationPaulina M Wojnarowicz, Raquel Lima E Silva, Masayuki Ohnaka, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Indian Journal of Medical Ethics|August 7, 2012
Proactive role for ethics committeesRashmi Kadam
Perspectives in Clinical Research|June 16, 2012
Ethics committees in India: Facing the challenges!Rashmi Kadam, Shashikant Karandikar
Autophagy|June 19, 2026
Optineurin, an autophagy adaptor, stabilizes Rictor to maintain Akt/mTOR signaling and antigen presentationRashmi Kadam, Deepak Shukla
Journal of Leukocyte Biology|June 13, 2024
Brain-immune interactions: implication for cognitive impairments in Alzheimer's disease and autoimmune disordersRashmi Kadam, Muskan Gupta, Orly Lazarov, et al.
Perspectives in Clinical Research|May 4, 2016
Opinions and perceptions regarding the impact of new regulatory guidelines: A survey in Indian Clinical Trial InvestigatorsRashmi Kadam, Sanghratna Borde, Sapna Madas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 4, 2026
Optineurin restrains IL-17-associated neuroinflammation in trigeminal ganglia to preserve sensory function after ocular HSV-1 infectionJoshua Ames, Rashmi Kadam, Tejabhiram Yadavalli, et al.
Clinical and Translational Medicine|June 10, 2025
MLKL‒OPTN axis regulates herpesvirus-induced neurological sequelaeIlina Bhattacharya, Rashmi Kadam, Tejabhiram Yadavalli, et al.
Cell Reports|April 17, 2026
Optineurin modulates mTORC2/AKT/STAT3 signaling to control MHC class II expression and adaptive immunity against HSV-1Rashmi Kadam, Chandrashekhar Patil, Leonid Feferman, et al.
Cell Reports|October 3, 2019
A Small-Molecule Pan-Id Antagonist Inhibits Pathologic Ocular NeovascularizationPaulina M Wojnarowicz, Raquel Lima E Silva, Masayuki Ohnaka, et al.
Pageof 1